1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
The use of a calcium antagonist (nifedipine) to suppress preterm labour
Article first published online: 22 AUG 2005
DOI: 10.1111/j.1471-0528.1986.tb08011.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 93, Issue 9, pages 933–937, September 1986
Additional Information
How to Cite
READ, M. D. and WELLBY, D. E. (1986), The use of a calcium antagonist (nifedipine) to suppress preterm labour. BJOG: An International Journal of Obstetrics & Gynaecology, 93: 933–937. doi: 10.1111/j.1471-0528.1986.tb08011.x
Publication History
- Issue published online: 22 AUG 2005
- Article first published online: 22 AUG 2005
- Received 4 June 1985, Accepted 6 December 1985
- Abstract
- References
- Cited By
Summary. The efficacy of an orally administered calcium antagonist, nifedipine, in suppressing premature uterine activity, was compared with intravenous ritodrine and no treatment. Nifedipine was found to be significantly more effective than ritodrine or withholding therapy, and was almost devoid of side-effects.